Page last updated: 2024-11-03

rimantadine and Anasarca

rimantadine has been researched along with Anasarca in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Research Excerpts

ExcerptRelevanceReference
"We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the alpha-methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis)."5.11Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series. ( Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singer, C1
Papapetropoulos, S1
Gonzalez, MA1
Roberts, EL1
Lieberman, A1

Trials

1 trial available for rimantadine and Anasarca

ArticleYear
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinso

2005